Wang, Cheng <br/><br/>
Design and optimization of orally spleen tyrosine kinase (SYK) inhibitors for treatment of solid tumor.  [electronic resource] 

 -  Bioorganic chemistry  01 2020 
 - 103547 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1090-2120 
<br/><br/><label>Standard No.: </label>10.1016/j.bioorg.2019.103547  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Antineoplastic Agents--administration & dosage<br/>Cell Line, Tumor<br/>Drug Design<br/>Humans<br/>Neoplasms--drug therapy<br/>Protein Kinase Inhibitors--administration & dosage<br/>Syk Kinase--antagonists & inhibitors